7 things to know about Enovis’ second quarter:
1. Sales growth: On top of an 11 percent revenue increase, Enovis saw a 3 percent increase in organic growth and a 5 percent increase in sales-per-day growth.
2. Operating income: Enovis’ operating income was $6 million.
3. Earnings per share: Enovis’ earnings per share increased to $0.59 from $0.41 in 2021.
4. Earnings before interest, taxes, depreciation and amortization: Enovis experienced an 11% growth in EBITA, reaching $56 million in the second quarter.
5. Acquisitions: Enovis completed the acquisition of Insight Medical Systems and 360 Med Care in quarter two.
6. Launches: Enovis launched a new version of its custom recovery boots, ProCare MaxTrax 2.0.
7. Future growth: Enovis is expecting a 6 to 9 percent growth throughout all of 2022.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
